With box warnings

Without box warnings

Branded

Generic

5 results

ahzantive
(aflibercept-mrbb)
Valorum Biologics Inc
Usage: AHZANTIVE is indicated for the treatment of neovascular (wet) age-related macular degeneration, macular edema following retinal vein occlusion, diabetic macular edema, and diabetic retinopathy.
byooviz
(ranibizumab-nuna)
BIOGEN INC.
Usage: BYOOVIZ is indicated for the treatment of patients with neovascular (wet) age-related macular degeneration (AMD), macular edema following retinal vein occlusion (RVO), and myopic choroidal neovascularization (mCNV).
cimerli
(ranibizumab-eqrn)
Coherus BioSciences Inc
Usage: CIMERLI is indicated for treating neovascular (wet) age-related macular degeneration, macular edema following retinal vein occlusion, diabetic macular edema, diabetic retinopathy, and myopic choroidal neovascularization.
eylea
(aflibercept)
Regeneron Pharmaceuticals, Inc.
Usage: EYLEA is indicated for treating neovascular (wet) age-related macular degeneration, macular edema following retinal vein occlusion, diabetic macular edema, diabetic retinopathy, and retinopathy of prematurity.
xipere
(triamcinolone acetonide)
Bausch & Lomb Incorporated
Usage: XIPERE® (triamcinolone acetonide injectable suspension) 40 mg/mL is indicated for treating macular edema associated with uveitis.

Medications for Macular Edema Cystoid

ahzantive